5-alpha-reductase deficiency classification: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{5-alpha-reductase deficiency}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==Referenc...")
 
 
(11 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{5-alpha-reductase deficiency}}
{{5-alpha-reductase deficiency}}
Please help WikiDoc by adding content here. It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
 
== Overview ==
There are two [[isoforms]] of [[5-alpha reductase]] named type 1 and type 2. Type 1 [[5-alpha reductase]] is found mostly in the [[skin]] and [[liver]], which can get delivered to the [[prostate]] by [[systemic circulation]]. Type 2 is found only on prostatic [[tissue]] and is the most common form. So, [[5-alpha-reductase]] [[deficiency]] is known as [[5-alpha-reductase]] 2 [[deficiency]].
 
== Classification ==
There is no classification of [[5-alpha reductase]] deficiency as type 2 [[5-alpha reductase]] [[deficiency]] is the most common one.[<ref name="pmid20395661">{{cite journal| author=Walter KN, Kienzle FB, Frankenschmidt A, Hiort O, Wudy SA, van der Werf-Grohmann N | display-authors=etal| title=Difficulties in diagnosis and treatment of 5alpha-reductase type 2 deficiency in a newborn with 46,XY DSD. | journal=Horm Res Paediatr | year= 2010 | volume= 74 | issue= 1 | pages= 67-71 | pmid=20395661 | doi=10.1159/000313372 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20395661 }} </ref>]
 
==References==
==References==
{{reflist|2}}
{{reflist|2}}
Line 8: Line 14:
[[Category:Needs content]]
[[Category:Needs content]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Endocrinology and Metabolic Disease]]
[[Category:Endocrinology]]
[[Category:Genetic disorders]]
[[Category:Genetic disorders]]

Latest revision as of 16:05, 23 December 2021

5-alpha-reductase deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating 5-alpha-reductase deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Molecular Genetic Studies

Genotyping

Pelvic X Ray

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

5-alpha-reductase deficiency classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of 5-alpha-reductase deficiency classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on 5-alpha-reductase deficiency classification

CDC on 5-alpha-reductase deficiency classification

5-alpha-reductase deficiency classification in the news

Blogs on 5-alpha-reductase deficiency classification

Directions to Hospitals Treating 5-alpha-reductase deficiency

Risk calculators and risk factors for 5-alpha-reductase deficiency classification

Overview

There are two isoforms of 5-alpha reductase named type 1 and type 2. Type 1 5-alpha reductase is found mostly in the skin and liver, which can get delivered to the prostate by systemic circulation. Type 2 is found only on prostatic tissue and is the most common form. So, 5-alpha-reductase deficiency is known as 5-alpha-reductase 2 deficiency.

Classification

There is no classification of 5-alpha reductase deficiency as type 2 5-alpha reductase deficiency is the most common one.[[1]]

References

  1. Walter KN, Kienzle FB, Frankenschmidt A, Hiort O, Wudy SA, van der Werf-Grohmann N; et al. (2010). "Difficulties in diagnosis and treatment of 5alpha-reductase type 2 deficiency in a newborn with 46,XY DSD". Horm Res Paediatr. 74 (1): 67–71. doi:10.1159/000313372. PMID 20395661.

Template:WH Template:WS